Search Within

Eric J Sherman

Formats
  1. Meeting Abstract (187)
  2. Journal Article (144)
  3. Review (6)
  4. Correspondence (5)
  5. Editorial (3)
  6. Research Letter (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (349)
  2. Head and Neck Service (349)
  3. Solid Tumor Oncology Division (349)
  4. Radiation Oncology, Department of (204)
  5. Surgery (172)
  6. Head and Neck Surgery (170)

More Groups

People
  1. Nancy Lee (200)
  2. Nadeem Riaz (149)
  3. David Pfister (127)
  4. Sean McBride (112)
  5. Richard Wong (110)
  6. Alan Ho (90)

More People

Years
  1. 2025 (10)
  2. 2024 (36)
  3. 2023 (24)
  4. 2022 (29)
  5. 2021 (21)
  6. 2020 (38)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (94)
  2. Journal of Clinical Oncology (85)
  3. Annals of Oncology (19)
  4. Cancer (16)
  5. Head & Neck (16)
  6. Oral Oncology (9)

More Publications

Publishers
  1. Elsevier Inc. (111)
  2. American Society of Clinical Oncology (87)
  3. Oxford University Press (28)
  4. Wiley Blackwell (26)
  5. John Wiley & Sons, Inc. (16)
  6. American Medical Association (11)

More Publishers

Results (349)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
    Journal Article

    Fury, M. G.; Xiao, H.; Sherman, E. J.; Baxi, S.; Smith-Marrone, S.; Schupak, K.; Gewanter, R.; Gelblum, D.; Haque, S.; Schoder, H.; more...
    Head & Neck (2016)

    Fulltext@MSK | Save
  • Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation
    Journal Article

    Romesser, P. B.; Cahlon, O.; Scher, E.; Zhou, Y.; Berry, S. L.; Rybkin, A.; Sine, K. M.; Tang, S.; Sherman, E. J.; Wong, R.; more...
    Radiotherapy and Oncology (2016)

    Fulltext@MSK | Save
  • Hypopharyngeal squamous cell carcinoma: Three-dimensional or intensity-modulated radiotherapy? A single institution's experience
    Journal Article

    Katsoulakis, E.; Riaz, N.; Hu, M.; Morris, L.; Sherman, E.; McBride, S.; Lee, N.
    Laryngoscope (2016)

    Fulltext@MSK | Save
  • Concurrent chemoradiotherapy with cisplatin versus cetuximab for squamous cell carcinoma of the head and neck
    Journal Article

    Riaz, N.; Sherman, E.; Koutcher, L.; Shapiro, L.; Katabi, N.; Zhang, Z.; Shi, W.; Fury, M.; Wong, R.; Wolden, S.; more...
    American Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Can metabolic tumor volume further risk stratify patients eligible for treatment deintensification in the newly proposed HPV-associated oropharyngeal cancer staging system?
    Meeting Abstract

    Romesser, P. B.; Ong, L.; Wong, R. J.; Sherman, E. J.; Riaz, N.; McBride, S. M.; Katabi, N.; Schoder, H.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Palliative radiation therapy by the RTOG 85-02 regimen for incurable primary or metastatic head and neck cancers
    Meeting Abstract

    Lok, B. H.; Jiang, G.; Gutiontov, S. I.; Lanning, R. M.; Sherman, E. J.; Tsai, C. J.; Riaz, N.; McBride, S. M.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers
    Journal Article

    Lok, B. H.; Chin, C.; Riaz, N.; Ho, F.; Hu, M.; Hong, J. C.; Shi, W.; Zhang, Z.; Sherman, E.; Wong, R. J.; more...
    Head & Neck (2015)

    Fulltext@MSK | Save
  • Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers
    Journal Article

    Lok, B. H.; Jiang, G.; Gutiontov, S.; Lanning, R. M.; Sridhara, S.; Sherman, E. J.; Tsai, C. J.; McBride, S. M.; Riaz, N.; Lee, N. Y.
    Oral Oncology (2015)

    Fulltext@MSK | Save
  • Combination of everolimus and sorafenib in the treatment of thyroid cancer: Update on phase II study
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Dunn, L.; Lee, J. S.; Lipson, B. L.; Pfister, D. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Assessment of second-line VEGF-inhibitor therapy in radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC)
    Meeting Abstract

    Dunn, L.; Ho, A. L.; Haque, S.; Fury, M. G.; Baxi, S. S.; Cullen, G.; Pfister, D. G.; Sherman, E. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save